HEALTHY HEART
CONGESTIVE HEARTH FAILURE
Cardiovascular diseases
Benefits of mesenchymal stem cells in cardiovascular diseases:
Myocardial infarction (heart attack):
Mesenchymal stem cells have shown ability to improve cardiac function, promote angiogenesis (formation of new blood vessels) and reduce scar tissue in animal models of myocardial infarction and in clinical trials, which could improve recovery and cardiac function after a heart attack.
Congestive heart failure:
Studies have shown that mesenchymal stem cells can improve cardiac function, reduce inflammation and promote cardiac tissue regeneration in patients with congestive heart failure, which may result in improved quality of life and fewer hospitalizations.
Multiple sclerosis (MS):
Mesenchymal stem cells have been shown to have immunomodulatory and anti-inflammatory properties that may reduce symptoms and progression of MS by modulating the immune response and promoting myelin regeneration.
Peripheral arterial disease (PAD):
Mesenchymal stem cells have shown beneficial effects in improving blood flow, promoting angiogenesis and reducing pain in patients with peripheral arterial disease by improving blood circulation and promoting the formation of new blood vessels in affected extremities.
Vascular injury and thrombosis:
Mesenchymal stem cells have been found to have anti-inflammatory, antioxidant and vascular tissue repair-promoting properties, which may be beneficial in the treatment of vascular injury and prevention of thrombus formation.
General Information
A blood sample from the patient is required at least 3 hours before the procedure to sensitize the MSC’s with the patient’s serum. Preferably take a blood sample 1 day before. When the patient is local and only has treatment with MSC’s, it may be easier to schedule the patient to come for sampling one day prior to their MSC’s treatment.
*Important; patients must pay in full 5 days prior to their scheduled treatment date to ensure fresh mesenchymal stem cells.
None of the patients have had any side effects as a result of the administration of mesenchymal stem cells.
